Cadrenal Therapeutics Inc - In December 2025

165 Views21 Feb 2026 01:00

Issuer-paid

In December 2025, Cadrenal Therapeutics, Inc. (CVKD) announced it had acquired VLX-1005, a first-in-class, selective 12-lipoxygenase (12-LOX)...

What is covered in the Full Insight:

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 12-minute read)

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream